Literature DB >> 18854406

Stringent regulation of oocyte donation in China.

Boon Chin Heng1.   

Abstract

Currently in China, health regulations permit oocyte donation only from IVF/ICSI patients who have 20 or more mature oocytes retrieved from a single cycle, of which at least 15 must be kept for their own treatment. Oocyte donation from non-patients and commercial transaction of human gametes are strictly prohibited by law. Additionally, embryos derived from donated oocytes must be cryopreserved and cannot be transferred to prospective recipients, until donors have been screened to be free of communicable diseases after 6 months. Such overly stringent regulation has in turn led to a severe shortage of available donor oocytes in China. The situation is made worse by a cultural aversion to oocyte donation by the majority of patients, because biological kinship and blood relations are viewed as sacrosanct in traditional Chinese culture. The harsh social stigmatization of childlessness in Chinese society, increasing incidence of age-related female infertility in recent years and growing numbers of bereaved older women who have lost their only child to accidents, natural disasters and suicides would make it imperative to reconsider liberalizing the regulation of oocyte donation in China. In particular, the blanket ban on oocyte donation by non-patients should be lifted, as it is anticipated that there are many young healthy women in China who are generous and open-minded enough to consider altruistically donating their oocytes to childless couples.

Entities:  

Mesh:

Year:  2008        PMID: 18854406     DOI: 10.1093/humrep/den352

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  Intra-Family Gamete Donation: A Solution to Concerns Regarding Gamete Donation in China?

Authors:  Juhong Liao; Katrien Devolder
Journal:  J Bioeth Inq       Date:  2016-06-15       Impact factor: 1.352

2.  Pregnancy outcome and follow-up of offspring of donor oocytes recipient from PCOS patients.

Authors:  Yan Jiang; Jing-Chuan Yuan; Ge Song; Xu-Hui Zhang; Sui-Bing Miao; Xiao-Hua Wu
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-19       Impact factor: 3.105

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.